“…In the Cardiovascular Health Study, the addition of 6 biomarkers (CRP, fibrinogen, factor VIIIc, interleukin-6, lipoprotein[a], and hemoglobin) did not improve discrimination beyond established risk factors among subjects with (difference ϭ 0.01, p ϭ 0.15) or without (difference ϭ 0.01, p ϭ 0.72) chronic kidney disease (32). In the Quebec Cardiovascular Study, an inflammation score based on interleukin-6 and fibrinogen levels moderately improved C-statistics (difference ϭ 0.008, p ϭ 0.03) for a CHD prediction model (33). Ridker et al (15,34) proposed the "Reynolds risk score," which included CRP, glycosylated hemoglobin (in women), and parental history of myocardial infarction in women (15) and men (34).…”